tirzepatide phase 1 A Multiple Dose Study of in Chinese Patients with Type 2 Diabetes Four Target Combination Therapy: GLP-1-GIP-GCG-IGF-1

5965 Village Way e207, San Diego, CA 92130 Other locations nearby

Ozempic (semaglutide injection) is a medication used to treat type 2 diabetes

View Study [4]"Safety and efficacy of subcutaneous Melanotan-II for tanning purposes" Ugwu SO, Blanchard J, Dorr RT, et al., 1997 Finding: Clinical testing showed MT-2 was well-tolerated at doses up to 0.03 mg/kg with predictable side effects (flushing, nausea)

Maskery M, Goulding EM, Gengler S, Melchiorsen JU, Rosenkilde MM, Holscher C

The rising prevalence of IBD worldwide and the ageing of the IBD population will likely increase the number of patients with metabolic comorbidities who may potentially benefit from a combination treatment with GLP-1 RAs